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ABSTRACT 
Objective: The present study was aimed to develop a simple, sensitive and precise high performance liquid chromatographic (HPLC) method for 
the simultaneous estimation of curcumin and piperine and to implement the developed method for the estimation of curcumin and piperine in the 
nanoparticulate formulation.  
Methods: Method development was performed using various solvent, buffer-solvent ratios, at different flow rates for adequate separation of both 
drugs. The developed method was validated in accordance with the international conference on harmonization (ICH) guidelines. The developed 
method was implemented to estimate the amount of curcumin and piperine in the nanoparticulate formulation.  
Results: Chromatographical conditions were optimized, and the best chromatographical conditions with adequate resolution for curcumin and 
piperine was achieved using enable C18G reverse phase column, using a mobile phase combination of acetonitrile and phosphate buffer (pH 3)in a 
ratio of 70:30 v/v at a flow rate of 1.0 ml/min. The detection was monitored at a wavelength of 360 nm. The retention time of curcumin and 
piperine was found to be 7.2 min and 8.5 min respectively.  
Conclusion: The developed analytical method is simple, precise, and reproducible and thus can be used for simultaneous estimation of curcumin 
and piperine in pharmaceutical formulations.  
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Curcumin is yellowish-orange crystalline phytochemical. It is a 
hydrophobic polyphenolic substance isolated from the rhizomes of 
Curcuma longa Linn. Family (Zingiberaceae). Structurally, curcumin 
is 1,7-bis (4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione 
as shown in fig. 1 along with other two de-methoxy compounds 
which are desmethoxycurcumin and bisdemethoxycurcumin [1, 2]. 
It possesses antioxidant, anti-inflammatory, anti-microbial and 
anticancer activity due to its diverse molecular targets [3, 4]. 
Curcumin is reported to be a potent antibacterial and anti-
hepatotoxic agent [5]. Safety of curcumin at very high doses has 
been proved in various animal and human studies. These studies led 
to the approval of curcumin as a ‘generally regarded as safe (GRAS)’ 
ingredient by the food and drug administration (FDA) of the United 
States of America, by the natural health products directorate of 
Canada and the expert joint committee [6]. 
Piperine is (1-piperoylpiperidine) as shown in fig. 1, an active alkaloid 
of Piper longum and Piper nigrum (Piperaceae) [7, 8]. It exhibits CNS 
depressant, antipyretic and anti-inflammatory activity [9]. It has been 
reported that piperine enhances the bioavailability of several drugs 
through inhibition of drug metabolism such as curcumin [10, 11]. 
Methods are available for the analysis of piperine [7, 12]. 
 
  
Curcumin      Piperine 
Fig. 1: Chemical structure of curcumin [1] and piperine [7] 
   
Several HPLC methods have been developed to quantify curcumin and 
piperine. In reported high-performance liquid chromatography 
(HPLC) method, the separation was observed at 9 and 9.5 min for 
curcumin and piperine respectively which is not desired to estimate 
the drug concentration in the formulation. While other reported 
method has used 0.1% orthophosphoric acid as mobile phase with pH 
2.1 which is less desirable and may damage the column [13].  
Hence, phosphate buffer was used, and pH was adjusted to 3 with 
ortho-phosphoric acid. 
In the reported method, the difference between retention time of 
curcumin and piperine was less, hence simultaneous estimation of 
this drugs was difficult in the nanoparticulate formulation. Also, the 
mobile phase used was highly acidic which may damage the column 
and may not show the desired results. So in the present work, a 
simple, precise, sensitive method was developed by using low-cost 
solvent acetonitrile with buffer pH 3 in ratio 70:30, detected by 
using UV visible detector. The developed method was used for 
estimation of curcumin from curcumin nanoparticles in which 
mobile phase was used for extraction of curcumin. 
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The primary objective of the study was to develop HPLC method for 
the simultaneous estimation of curcumin and piperine with 
adequate separation and to validate developed method according to 
ICH guidelines [14]. 
MATERIALS AND METHODS 
Chemicals and reagents 
Curcumin was kindly supplied by VAV life sciences Pvt. Ltd. 
(Mumbai), India and piperine were supplied from Sigma-aldrich, 
India. Methanol and acetonitrile used were of HPLC grade and 
obtained from Rankem and Loba-Chemie, India respectively. 
Purified water used was of HPLC grade, obtained from Merck Labs 
(Mumbai), India. Other reagents were of analytical grade including 
potassium dihydrogen orthophosphate, the orthophosphoric acid 
obtained from Loba-Chemie, India. 
Nanoparticulate formulation 
It was prepared by modified hot melt emulsification/ultrasonication 
technique using lipids and surfactants at Vivekanand Education 
Society’s College of Pharmacy Chembur, Mumbai. Solid lipid precirol 
ATO5, liquid lipid labrafac lipophile WL 1349 and surfactant gelucire 
50/13 used for nanoparticulate formulation were kindly gifted by 
Gattefosse, India. Surfactant tween 80 was gifted by BASF, India. The 
prepared nanoparticulate formulation labeled to contain 8 mg 
curcumin and 4 mg piperine per 10 ml.  
Instruments used 
Analyses were carried out using shimadzu HPLC-MD2010-UV system 
equipped with the pump and UV/VIS detector. The generated 
analytical signals were monitored and integrated using chrompass 
data software. The chromatographic separation was performed using 
enable C18G (250 mm x 4.6 mm x 5 µm) reverse phase column. 
Methods 
The method development for the simultaneous estimation of 
curcumin and piperine was performed using a different flow rate, 
elution mode, different mobile phase and buffer ratio [1, 2]. 
Preparation of stock solution 
Stock solutions of curcumin and piperine were prepared by 
dissolving 10 mg of each in 10 ml of methanol to give 1000 μg/ml. 
All solutions were prepared in amber glassware as curcumin and 
piperine have poor light stability. 
Preparation of working standard 
Different working solutions containing curcumin and piperine were 
obtained by dilution of stock solutions with methanol. 
Mobile phase preparation 
Potassium dihydrogen orthophosphate of about 1.7011 g was 
weighed accurately and solubilized in mill Q water (500 ml), and pH 
was adjusted with orthophosphoric acid to 3.5 (solution A). A 
mixture of solution A and acetonitrile (30:70 %v/v) were mixed, 
degassed and used as mobile phase. 
Method validation 
The developed method was validated in compliance with ICH guideline 
for system suitability, accuracy, precision, limit of detection (LOD), limit 
of quantitation (LOQ), linearity, range, and robustness in accordance 
with ICH guideline for analytical procedures Q2(R1) [14]. 
System suitability 
Six replicate samples containing curcumin and piperine were analyzed 
using the developed method. Theoretical plate count more than 3000, 
tailing less than 1.5 and percentage relative standard deviation (% RSD) 
less than 2% of peak area was set as acceptance criteria. 
Linearity 
The linearity was evaluated at five concentration levels in the range 
between 5-25 µg/ml for both curcumin and piperine. The calibration 
curve was plotted by plotting concentration against its 
corresponding peak area, and linearity was determined using least 
square regression analysis. The slope value and correlation 
coefficient (r2
Precision (Repeatability) 
) values were calculated separately for each drug. 
The precision of the method is determined to check repeatability. Inter-
day and intra-day precision studies were carried out at three different 
concentrations (12, 15 and 18 μg/ml) by injecting each sample three 
times and % RSD of estimated concentration was determined.  
Accuracy (Recovery) 
The accuracy of the method was determined by spiking the pre-
analysed samples of curcumin and piperine with a known amount of 
standard solution (80, 100 and 120 %) and its recovery was 
estimated using the developed method. It was determined as the 
percentage difference between the expected and measured drug 
concentrations. Percentage recovery within 100±2% and % RSD of 
assay less than 2 % was set as acceptance criteria.  
LOD and LOQ 
LOD is the smallest concentration of analyte that gives response an 
accurately but not necessarily quantified as an exact value. LOQ is the 
least concentration of the analyte that gives an accurate response. The 
LOD and LOQ were calculated by using the standard deviation of 









Robustness and ruggedness 
These parameters were studied by carrying out experiments by 
changing the chromatographic conditions such as pH, flow rate and 
column temperature. 
Application of the validated method for the assay of the 
curcumin-piperine nanoparticulate formulation 
Sample preparation  
1 ml of the curcumin-piperine nanoparticulate formulation (0.8 
μg/ml curcumin and 0.4 μg/ml piperine) transferred into 10 ml of 
volumetric flask. 7 ml of methanol was added and sonicated for 60 
min for complete extraction. The sonicated solution was cooled 
down to room temperature, and volume was made up with 
methanol, mixed and filtered through 0.45μ nylon syringe filter. 
From the above solution, 1 ml was pipetted out and transferred to a 
10 ml volumetric flask. Volume was made up with diluents to get a 
final concentration of 8 μg/ml curcumin and 4 μg/ml piperine. 20 μl 
of standard solutions was injected into HPLC system, chromatogram 
was recorded, and percent assay or recovery was calculated. 
RESULTS AND DISCUSSION 
Method development 
The method development for estimation of curcumin and piperine was 
carried out using various mobile phases including acetonitrile: 0.1% 
orthophosphoric acid, methanol: water and acetonitrile: water to achieve 
separation of curcumin and piperine. These systems were unable to 
show two separate peaks for both the drugs. It was found that separation 
was best achieved using acetonitrile: phosphate buffer with pH 3. Also, 
various solvent-buffer ratios were tried such as (45:55, 60:40, 50:50 and 
70:30). Combination of acetonitrile and phosphate buffer pH 3 at 70:30 
v/v ratios has shown good resolution of curcumin and piperine. The 
optimum wavelength was selected for the estimation of curcumin and 
piperine was 360 nm based on the maximum absorption using a UV-
Visible spectrophotometer. Initially, 0.8 ml/min flow rate was used but 
the increase in flow rate from 0.8 to 1 ml showed adequate separation 
and high theoretical plates. The flow rate of 1.2 ml/min did not show 
adequate separation of curcumin and piperine. Similarly, isocratic 
elution mode has shown better separation in comparison with gradient 
elution mode. 
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The optimum chromatographic condition with adequate resolution 
for curcumin and piperine was achieved when the separation was 
carried using enable C18
 
 column (250 mm x 4.6 mm, 5 μ) at 35 °C 
temperature with an isocratic elution mode of mobile phase 
composed of a degassed mixture of acetonitrile: phosphate buffer pH 
3 (70:30 v/v) at 1.0 ml/min flow rate with a total run time of 15 min 
where retention time for curcumin and piperine was observed at 7.2 
and 8.69 min respectively as shown in fig. 2. 
 




The developed method indicated theoretical plates above 2000 with 
tailing factor less than 1.5 for both drugs curcumin and piperine. 
Similarly, the %RSD of peak area and retention time of curcumin 
was less than 2, which ensures the suitability of the developed 
method. The results of system suitability study are summarized in 
table 1. 
Acceptance criteria 
1. The relative standard deviation of six replicate injections for 
peak area and retention time should not be more than 2.0%.  
2. The tailing factor should not be more than 1.5. 
3. The theoretical plates should be more than 3000. 
Linearity and range 
The correlation coefficient (r2
Precision 
) of curcumin and piperine was found 
to be 0.9994 and 0.9993 as given in fig. 3 and 4 respectively which 
confirms that acceptable linearity was obtained in the range of 5-25 
µg/ml. The results of linearity are summarized in table 2. 
The developed method has shown % RSD less than 1.5 for peak area 
for both intra-day and inter-day precision study, which ensures 
precision of the developed method. The results of intra-day and 
inter-day precision study are summarized in table 3 and 4. 
Acceptance criteria: The % RSD for retention time and peak area 
should be NMT 2.0%. 
 
Table 1: System suitability of the developed method 
Sample Retention time (min) %RSD* USP tailing factor USP theoretical plates 
Curcumin 7.20 0.86 1.026 7103 
Piperine 8.70 0.93 1.094 8087 
Data given in this table is presented as mean, n=3, RSD: Relative standard deviation. 
 
Table 2: Linearity and range of the developed method 
Conc (μg/ml) Peak area (mAU*sec) (mean±SD) 
Curcumin Piperine 
5 80566±854.40 232297±1024.80 
10 286716±987.72 843803±959.18 
15 513435±706.06 1470932±1219.52 
20 753277±734.18 2162255±637.99 
25 965423±906.49 2725927±988.75 
Linearity equation y = 44726x–150999 y = 126114x–404671 
Correlation coefficient r² = 0.9994 r² = 0.9993 
Data given in this table is presented as mean±SD, n=3, SD: Standard deviation. 
 
 
Fig. 3: Linearity plot of curcumin. (Data given in mean±SD) (n=3), SD: standard deviation 
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Fig. 4: Linearity plot of piperine, (Data given in mean±SD) (n=3), SD: standard deviation 
 
Table 3: Intra-day precision of the developed method 
Conc (μg/ml) Curcumin Piperine 
retention time (min) Area (mAU*sec) 
(mean±SD) 
% RSD retention time (min) Area(mAU*sec) 
(mean±SD) 
% RSD 
12 7.30 552024.7±10606.31 1.57 8.72 1712079±4273.05 0.27 
15 7.26 673719.7±5563.48 0.83 8.69 2092002±2883.76 0.14 
18 7.28 800087±444.16 0.06 8.73 2460887±1304.81 0.05 
Data given in this table is presented as mean±SD, n=3, SD: Standard deviation, RSD: Relative standard deviation. 
 
Table 4: Inter-day precision of the developed method 
Conc (μg/ml) Curcumin Piperine 
retention time (min) Area (mAU*sec) 
(mean±SD) 
% RSD retention time (min) Area (mAU*sec) 
(mean±SD) 
% RSD 
12 7.30 558752.3±801.78 0.12 8.74 1717727±1654.13 0.03 
15 7.28 674443±4636.57 0.74 8.75 2066546±1673.01 0.08 
18 7.26 805796.7±6696.03 0.83 8.72 2449613±5243.75 0.21 
Data given in this table is presented as mean±SD, n=3, SD: Standard deviation, RSD: Relative standard deviation. 
 
Accuracy 
The percentage recovery of the spiked curcumin and piperine was 
within 100±2% which ensures the accuracy of the developed 
method. The results of recovery studies were summarized in table 5 
and 6. 
Acceptance criteria: % Recovery should be between 98-102%. 
 
Table 5: Accuracy of the developed method for curcumin 
Level in (%) Amount spiked (μg) Amount recovered (μg) % Recovery % RSD 
80 12 12.070 100.26 0.46 
80 12 12.26 100.97 
80 12 12.31 101.13 
100 15 15.58 101.93 0.86 
100 15 15.11 100.36 
100 15 15.15 100.50 
120 18 17.60 98.78 0.68 
120 18 17.93 99.80 
120 18 18.02 100.06 
RSD: Relative standard deviation  
 
Table 6: Accuracy of the developed method for piperine 
Level in (%) Amount spiked (μg) Amount recovered (μg) % Recovery % RSD 
80 12 11.93 99.73 0.19 
80 12 11.86 99.48 
80 12 11.83 99.36 
100 15 14.71 99.04 0.01 
100 15 14.72 99.06 
100 15 14.72 99.06 
120 18 17.40 98.19 0.19 
120 18 17.29 97.85 
120 18 17.39 98.15 
RSD: Relative standard deviation  
Hirlekar et al. 
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LOD and LOQ 
The LOD for curcumin and piperine were found to be 0.73 µg/ml and 
0.82 µg/ml respectively, while LOQ for curcumin and piperine were 
found to be 2.21 µg/ml and 2.49µg/ml respectively. 
Robustness and ruggedness 
The method is found to be rugged and robust since there were no 
changes in the chromatogram by changing the chromatographic 
conditions such as slight changes in flow rate (0.8-1.2 ml/min), 
column oven temperature (30-40⁰C) and pH of mobile phase (2.8-
3.2). These changes did not show influence on retention time or area 
of both drugs. 
Application of the validated method for the assay of the 
curcumin-piperine nanoparticulate formulation  
The developed method was successfully implemented in the 
estimation of curcumin and piperine in the nanoparticulate 
formulation. Assay of curcumin and piperine was found to be 98.3 
and 105.1 % respectively. The results are summarized in table 7. 
 
Table 7: Assay of curcumin and piperine 
Parameter Curcumin Piperine 
Amount recovered (mg) 7.86 4.20 
%RSD* 0.22 0.24 
Assay (%) 98.30 105.10 
Data given in this table is presented in mean, n=3, RSD: Relative standard deviation.  
 
In order to develop a suitable RP-HPLC method for the estimation of 
curcumin and piperine, different buffer ratios at different flow rate 
were applied. The reported methods were costly due to the use of 
highly sophisticated instruments like reverse phase ultrafast liquid 
chromatographic (RP-UFLC) system [8], HPLC-MS/MS [15] and 
detectors like fluorescence detectors [10]. An expensive solvent such 
as trifluoroacetic acid [1] was replaced by the combination of 
acetonitrile and phosphate buffer pH 3 in this study. The LOD and LOQ 
for curcumin were found to be 0.7303 and 2.2130 μg/ml, respectively 
whereas LOD and LOQ for piperine were found to be 0.8204 and 
2.4862 μg/ml, which indicates that the method was sensitive, and can 
detect and quantify at lower levels of curcumin and piperine. Linearity 
range was from 5-25 μg/ml for both curcumin and piperine with 
regression coefficients of 0.9994 and 0.9993 respectively indicates 
that at this concentration range both curcumin and piperine were 
highly linear. Percent assay of curcumin and were found to be 98.3% 
and 105.1 respectively. The developed RP-HPLC assay method was 
found to be appropriate for the analysis of the drug in their pure form 
and in the nanoparticulate formulation. 
CONCLUSION 
In this study simple, accurate and cost-effective reversed-phase HPLC 
method was developed for the simultaneous estimation of curcumin and 
piperine with mobile phase degassed mixture of acetonitrile: phosphate 
buffer pH 3 (70:30 v/v) at 1.0 ml/min flow rate which is suitable for 
column efficiency. The retention time difference found 7.2 and 8.69 min 
for curcumin and piperine respectively which ensures precise estimation 
of both drugs in the nanoparticulate formulation. The developed method 
was validated as per ICH guidelines and statistical analysis also proved 
that the method is linear, precise, accurate and specific for the analysis of 
curcumin and piperine. The method is linear with a correlation 
coefficient 0.999 for both drugs. The accuracy of the method is in the 
range of 98.68 % to 102.93 %. The developed method was successfully 
implemented in the estimation of curcumin-piperine in the nanoparticulate 
formulation. Thus, the developed method can be used for routine analysis 
of curcumin and piperine in pharmaceutical dosage forms. 
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